[144] Inter & Co. Inc. SEC Filing
Rhea-AI Filing Summary
Inter&Co, Inc. (INTR) filed a Form 144 notifying a proposed sale of 10,000 Class A shares to be executed through Inter&Co Securities, LLC on Nasdaq with an aggregate market value of $77,700 and an approximate sale date of 08/08/2025. The shares were acquired on 06/23/2022 in a business combination transaction registered on Form F-4, representing an exchange of Banco Inter shares. The filer sold 900 Class A shares on 05/27/2025 for $6,480. The notice affirms the filer is not aware of undisclosed material adverse information and includes standard Rule 144 representations.
Positive
- Filed in compliance with Rule 144, providing required disclosure of proposed sale
- Acquisition history documented (business combination via Form F-4), clarifying provenance of shares
- Filer attests to absence of undisclosed material adverse information
Negative
- Insider selling shares (10,000 proposed, plus 900 sold on 05/27/2025), which could increase supply
- No disclosure of a 10b5-1 trading plan on the form, leaving the motive and timing framework unspecified
Insights
TL;DR: Form 144 reports a registered insider sale of 10,000 Class A shares worth $77,700, following a small sale in May.
The filing documents a planned disposition of restricted or control securities under Rule 144, consistent with compliance and public disclosure obligations. The size of the proposed sale, relative to the 323,014,076 shares outstanding, is immaterial to market capitalization but is relevant for monitoring insider liquidity and potential supply into the market. Prior sale of 900 shares in May shows recent selling activity by the same person. No financial performance or forward-looking metrics are presented in this notice.
TL;DR: The Form 144 reflects routine insider reporting and attests to absence of undisclosed material information.
The form includes the required attestations and traces acquisition back to a Form F-4 exchange, indicating lawful acquisition and transfer mechanics. The filer’s representation that no undisclosed material adverse information exists is standard and important for compliance. There is no indication of a trading plan or 10b5-1 arrangement disclosed on the form. Governance implications are routine; the filing neither signals governance breaches nor material disclosures beyond the sale intent.